Notch ankyrin repeat domain variation influences leukemogenesis and Myc transactivation.

The functional interchangeability of mammalian Notch receptors (Notch1-4) in normal and pathophysiologic contexts such as cancer is unsettled. We used complementary in vivo, cell-based and structural analyses to compare the abilities of activated Notch1-4 to support T cell development, induce T cell...

Full description

Bibliographic Details
Main Authors: Jon C Aster, Nick Bodnar, Lanwei Xu, Fredrick Karnell, John M Milholland, Ivan Maillard, Gavin Histen, Yunsun Nam, Stephen C Blacklow, Warren S Pear
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2011-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3192765?pdf=render
_version_ 1811281765592989696
author Jon C Aster
Nick Bodnar
Lanwei Xu
Fredrick Karnell
John M Milholland
Ivan Maillard
Gavin Histen
Yunsun Nam
Stephen C Blacklow
Warren S Pear
author_facet Jon C Aster
Nick Bodnar
Lanwei Xu
Fredrick Karnell
John M Milholland
Ivan Maillard
Gavin Histen
Yunsun Nam
Stephen C Blacklow
Warren S Pear
author_sort Jon C Aster
collection DOAJ
description The functional interchangeability of mammalian Notch receptors (Notch1-4) in normal and pathophysiologic contexts such as cancer is unsettled. We used complementary in vivo, cell-based and structural analyses to compare the abilities of activated Notch1-4 to support T cell development, induce T cell acute lymphoblastic leukemia/lymphoma (T-ALL), and maintain T-ALL cell growth and survival.We find that the activated intracellular domains of Notch1-4 (ICN1-4) all support T cell development in mice and thymic organ culture. However, unlike ICN1-3, ICN4 fails to induce T-cell acute lymphoblastic leukemia/lymphoma (T-ALL) and is unable to rescue the growth of Notch1-dependent T-ALL cell lines. The ICN4 phenotype is mimicked by weak gain-of-function forms of Notch1, suggesting that it stems from a failure to transactivate one or more critical target genes above a necessary threshold. Experiments with chimeric receptors demonstrate that the Notch ankyrin repeat domains differ in their leukemogenic potential, and that this difference correlates with activation of Myc, a direct Notch target that has an important role in Notch-associated T-ALL.We conclude that the leukemogenic potentials of Notch receptors vary, and that this functional difference stems in part from divergence among the highly conserved ankyrin repeats, which influence the transactivation of specific target genes involved in leukemogenesis.
first_indexed 2024-04-13T01:39:31Z
format Article
id doaj.art-3613db6e838241a1a8c60558210c4dbf
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-13T01:39:31Z
publishDate 2011-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-3613db6e838241a1a8c60558210c4dbf2022-12-22T03:08:13ZengPublic Library of Science (PLoS)PLoS ONE1932-62032011-01-01610e2564510.1371/journal.pone.0025645Notch ankyrin repeat domain variation influences leukemogenesis and Myc transactivation.Jon C AsterNick BodnarLanwei XuFredrick KarnellJohn M MilhollandIvan MaillardGavin HistenYunsun NamStephen C BlacklowWarren S PearThe functional interchangeability of mammalian Notch receptors (Notch1-4) in normal and pathophysiologic contexts such as cancer is unsettled. We used complementary in vivo, cell-based and structural analyses to compare the abilities of activated Notch1-4 to support T cell development, induce T cell acute lymphoblastic leukemia/lymphoma (T-ALL), and maintain T-ALL cell growth and survival.We find that the activated intracellular domains of Notch1-4 (ICN1-4) all support T cell development in mice and thymic organ culture. However, unlike ICN1-3, ICN4 fails to induce T-cell acute lymphoblastic leukemia/lymphoma (T-ALL) and is unable to rescue the growth of Notch1-dependent T-ALL cell lines. The ICN4 phenotype is mimicked by weak gain-of-function forms of Notch1, suggesting that it stems from a failure to transactivate one or more critical target genes above a necessary threshold. Experiments with chimeric receptors demonstrate that the Notch ankyrin repeat domains differ in their leukemogenic potential, and that this difference correlates with activation of Myc, a direct Notch target that has an important role in Notch-associated T-ALL.We conclude that the leukemogenic potentials of Notch receptors vary, and that this functional difference stems in part from divergence among the highly conserved ankyrin repeats, which influence the transactivation of specific target genes involved in leukemogenesis.http://europepmc.org/articles/PMC3192765?pdf=render
spellingShingle Jon C Aster
Nick Bodnar
Lanwei Xu
Fredrick Karnell
John M Milholland
Ivan Maillard
Gavin Histen
Yunsun Nam
Stephen C Blacklow
Warren S Pear
Notch ankyrin repeat domain variation influences leukemogenesis and Myc transactivation.
PLoS ONE
title Notch ankyrin repeat domain variation influences leukemogenesis and Myc transactivation.
title_full Notch ankyrin repeat domain variation influences leukemogenesis and Myc transactivation.
title_fullStr Notch ankyrin repeat domain variation influences leukemogenesis and Myc transactivation.
title_full_unstemmed Notch ankyrin repeat domain variation influences leukemogenesis and Myc transactivation.
title_short Notch ankyrin repeat domain variation influences leukemogenesis and Myc transactivation.
title_sort notch ankyrin repeat domain variation influences leukemogenesis and myc transactivation
url http://europepmc.org/articles/PMC3192765?pdf=render
work_keys_str_mv AT joncaster notchankyrinrepeatdomainvariationinfluencesleukemogenesisandmyctransactivation
AT nickbodnar notchankyrinrepeatdomainvariationinfluencesleukemogenesisandmyctransactivation
AT lanweixu notchankyrinrepeatdomainvariationinfluencesleukemogenesisandmyctransactivation
AT fredrickkarnell notchankyrinrepeatdomainvariationinfluencesleukemogenesisandmyctransactivation
AT johnmmilholland notchankyrinrepeatdomainvariationinfluencesleukemogenesisandmyctransactivation
AT ivanmaillard notchankyrinrepeatdomainvariationinfluencesleukemogenesisandmyctransactivation
AT gavinhisten notchankyrinrepeatdomainvariationinfluencesleukemogenesisandmyctransactivation
AT yunsunnam notchankyrinrepeatdomainvariationinfluencesleukemogenesisandmyctransactivation
AT stephencblacklow notchankyrinrepeatdomainvariationinfluencesleukemogenesisandmyctransactivation
AT warrenspear notchankyrinrepeatdomainvariationinfluencesleukemogenesisandmyctransactivation